We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
-12.58%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$43.6B
AUM Growth
-$9.03B
(-17%)
Cap. Flow
-$1.48B
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
21.41%
Holding
1,190
New
110
Increased
278
Reduced
409
Closed
115
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$364M |
| 2 |
SIVB
SVB Financial Group
SIVB
|
+$155M |
| 3 |
Textron
TXT
|
+$103M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$102M |
| 5 |
Sanofi
SNY
|
+$96.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$333M |
| 2 |
ExxonMobil
XOM
|
+$242M |
| 3 |
Dollar Tree
DLTR
|
+$231M |
| 4 |
Nutrien
NTR
|
+$213M |
| 5 |
National Vision
EYE
|
+$198M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.53% |
| 2 | Healthcare | 17.73% |
| 3 | Financials | 14.85% |
| 4 | Consumer Discretionary | 9.35% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Arista Networks
ANET
$240B
| $19.6M | 0.05% |
837,600
+800
| +0.1% | +$21.9K |
|
|
COLI
427
DELISTED
Colicity Inc. Class A Common Stock
COLI
| $19.6M | 0.05% |
2,000,000
| – | – |
|
|
WPCA
428
DELISTED
Warburg Pincus Capital Corporation I-A
WPCA
| $19.6M | 0.05% |
2,000,000
| – | – |
|
|
PICC
429
DELISTED
Pivotal Investment Corporation III
PICC
| $19.6M | 0.05% |
2,000,000
| – | – |
|
|
LGAC
430
DELISTED
Lazard Growth Acquisition Corp. I Ordinary Shares
LGAC
| $19.6M | 0.04% |
2,000,000
| – | – |
|
|
TCVA
431
DELISTED
TCV Acquisition Corp. Class A Ordinary Shares
TCVA
| $19.5M | 0.04% |
2,000,000
| – | – |
|
432
Ulta Beauty
ULTA
$23.4B
| $19.5M | 0.04% |
50,492
-2,158
| -4% | -$858K |
|
433
Ball Corp
BALL
$17B
| $19.5M | 0.04% |
282,997
-457,508
| -62% | -$34.7M |
|
434
Citizens Financial Group
CFG
$31.1B
| $19.5M | 0.04% |
+545,219
| New | +$21.5M |
|
435
Microchip Technology
MCHP
$43.8B
| $19.5M | 0.04% |
335,000
-1,600
| -0.5% | -$106K |
|
436
Martin Marietta Materials
MLM
$33.4B
| $19.4M | 0.04% |
64,939
-200
| -0.3% | -$68.2K |
|
437
CenterPoint Energy
CNP
$27.4B
| $19.4M | 0.04% |
655,538
-1,100
| -0.2% | -$33.8K |
|
|
GFGD
438
DELISTED
The Growth for Good Acquisition Corporation Class A Ordinary Shares
GFGD
| $19.4M | 0.04% |
1,980,000
| – | – |
|
439
AngioDynamics
ANGO
$628M
| $19.4M | 0.04% |
1,000,000
-182,707
| -15% | -$3.74M |
|
|
ATC
440
DELISTED
Atotech Limited
ATC
| $19.2M | 0.04% |
992,170
+400,300
| +68% | +$8.27M |
|
441
Paylocity
PCTY
$7.67B
| $19.2M | 0.04% |
110,000
+55,000
| +100% | +$10M |
|
442
Xenon Pharmaceuticals
XENE
$6.19B
| $19.2M | 0.04% |
630,000
-20,000
| -3% | -$605K |
|
|
DLCA
443
DELISTED
Deep Lake Capital Acquisition Corp. Class A Ordinary Shares
DLCA
| $19.1M | 0.04% |
1,944,469
| – | – |
|
444
ASML
ASML
$658B
| $19M | 0.04% |
+40,000
| New | +$22.3M |
|
445
Lennar Class A
LEN
$21B
| $19M | 0.04% |
278,204
-3,719
| -1% | -$272K |
|
|
K
446
DELISTED
Kellanova
K
| $18.8M | 0.04% |
281,093
+78,917
| +39% | +$5.13M |
|
447
ReNew
RNW
$2.29B
| $18.7M | 0.04% |
2,885,217
-200,000
| -6% | -$1.44M |
|
448
Fastenal
FAST
$57B
| $18.6M | 0.04% |
747,012
-738,128
| -50% | -$19.9M |
|
449
CF Industries
CF
$18.1B
| $18.6M | 0.04% |
217,222
-656,700
| -75% | -$63.8M |
|
450
Nasdaq
NDAQ
$52.3B
| $18.3M | 0.04% |
360,240
+68,400
| +23% | +$3.62M |
|
Similar funds
Adage Capital Partners's Q2 2022 Portfolio in Review
As of Q2 2022, Adage Capital Partners held 1,190 positions worth $43.6B, down 17% from $52.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Adage Capital Partners withdrew a net $1.48B in Q2 2022, closing 115 positions and reducing 409 holdings. Its most notable exit was Nutrien, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Booz Allen Hamilton worth $75.6M.
- Adage Capital Partners's largest Q2 2022 buy was Booz Allen Hamilton: 837,064 shares worth $75.6M.
- Adage Capital Partners added most to Biohaven Pharmaceutical Holding Company Ltd. in Q2 2022, an estimated $364M increase.
- Adage Capital Partners's biggest Q2 2022 reduction was Royalty Pharma, cutting an estimated $333M.
- Adage Capital Partners fully exited Nutrien in Q2 2022, selling an estimated $213M.
- Adage Capital Partners's ten largest holdings make up 21% of its $43.6B portfolio in Q2 2022.
- Adage Capital Partners opened 110 new positions and closed 115 in Q2 2022.
- Adage Capital Partners's portfolio value fell 17% quarter-over-quarter to $43.6B.
Based on Adage Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.